XSHE
002004
Market cap1.19bUSD
Jul 10, Last price
4.13CNY
1D
1.23%
1Q
-22.22%
Jan 2017
-54.47%
IPO
256.03%
Name
Huapont Life Sciences Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Huapont Life Sciences Co., Ltd. is a multifaceted company engaged in both the pharmaceutical and agrochemical industries, with operations spanning China and international markets. Its pharmaceutical arm is dedicated to the manufacture and distribution of medicinal preparations and their precursors. The company offers a broad range of healthcare products, including treatments for skin conditions, tuberculosis, infections, respiratory issues, cancer, and eye ailments, in addition to general wellness products. Within its agrochemical division, Huapont supplies technical pesticides, intermediates, and finished products, alongside providing technical services for GLP registration. Founded in 2001 and based in Chongqing, China, the company adopted its current name, Huapont Life Sciences Co., Ltd., in September 2015, having previously been known as Huapont-Nutrichem Co., Ltd. It was formerly a subsidiary of Huipont Tourism Co. Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2021‑00 | 2020‑12 | 2019‑12 | 2019‑00 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||||
Revenues | ||||||||||||||
Cost of revenue | ||||||||||||||
Unusual Expense (Income) | ||||||||||||||
NOPBT | ||||||||||||||
NOPBT Margin | ||||||||||||||
Operating Taxes | ||||||||||||||
Tax Rate | ||||||||||||||
NOPAT | ||||||||||||||
Net income | ||||||||||||||
Dividends | ||||||||||||||
Dividend yield | ||||||||||||||
Proceeds from repurchase of equity | ||||||||||||||
BB yield | ||||||||||||||
| Debt | ||||||||||||||
Debt current | ||||||||||||||
Long-term debt | ||||||||||||||
Deferred revenue | ||||||||||||||
Other long-term liabilities | ||||||||||||||
Net debt | ||||||||||||||
| Cash flow | ||||||||||||||
Cash from operating activities | ||||||||||||||
CAPEX | ||||||||||||||
Cash from investing activities | ||||||||||||||
Cash from financing activities | ||||||||||||||
FCF | ||||||||||||||
| Balance | ||||||||||||||
Cash | ||||||||||||||
Long term investments | ||||||||||||||
Excess cash | ||||||||||||||
Stockholders' equity | ||||||||||||||
Invested Capital | ||||||||||||||
ROIC | ||||||||||||||
ROCE | ||||||||||||||
| EV | ||||||||||||||
Common stock shares outstanding | ||||||||||||||
Price | ||||||||||||||
Market cap | ||||||||||||||
EV | ||||||||||||||
EBITDA | ||||||||||||||
EV/EBITDA | ||||||||||||||
Interest | ||||||||||||||
Interest/NOPBT | ||||||||||||||